IP Verse

Immunoglobulin Preparation - EP2531218

The patent EP2531218 was granted to CSL Behring on Dec 12, 2018. The application was originally filed on Feb 3, 2011 under application number EP11702054A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2531218

CSL BEHRING
Application Number
EP11702054A
Filing Date
Feb 3, 2011
Status
Granted And Under Opposition
Nov 9, 2018
Grant Date
Dec 12, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

UCB BIOPHARMASep 11, 2019UCBWITHDRAWN

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2005049078
INTERNATIONAL-SEARCH-REPORTEP1532983
INTERNATIONAL-SEARCH-REPORTUS5871736
OPPOSITIONUS2006051347
OPPOSITIONWO2005049078
OPPOSITIONWO2011034604

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Anonymous, "Falling Ball Viscosimeter", Brookfield, page 2pp
OPPOSITION- Anonymous, "Scale-up of a downstream monoclonal antibody purification process using HiScreen™ and AxiChrom™ columns", GE Healthcare Application note 28-9403-49 AA, (20090900), pages 1 - 8, XP055641648
OPPOSITION- BRAUN et al., "The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications", West Journal of Medicine, (19920000), vol. 157, pages 158 - 168, XP055641640
OPPOSITION- KUMAR et al., "The role of proline in the prevention of aggregation during protein folding in vitro", Biochemistry and Molecular Biology International, (199810), vol. 46, no. 3, pages 509 - 517, XP055641654
OPPOSITION- SHIRE et al., "Challenges in the development of high protein concentration formulations", Journal of Pharmaceutical sciences, (20040000), vol. 93, no. 6, pages 1390 - 1402, XP009108986
OPPOSITION- LIU et al., "Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution", Journal of Pharmaceutical sciences, (20050000), vol. 94, no. 9, pages 1928 - 1940, XP002475004
OPPOSITION- WANG et al., "ANTIBODY STRUCTURE, INSTABILITY, AND FORMULATION", Journal of Pharmaceutical sciences, (20070000), vol. 96, no. 1, pages 1 - 26, XP009084505
OPPOSITION- VAN REIS et al., "LINEAR SCALE ULTRAFILTRATION", Biotechnology & Bioengineering, (19970000), vol. 55, pages 737 - 746, XP000699680
OPPOSITION- BOLLI et al., "L-Proline reduces IgG dimer content and enhances the stability of intravenous immunoglobulin (IVIG) solutions", Biologicals, (20100100), vol. 38, no. 1, pages 150 - 157, XP026978067
OPPOSITION- MAEDER et al., "Stability over 24 Months and Tolerability of a New 20% Proline-stabilized Polyclonal Immunoglobulin for Subcutaneous Administration (SCIG)", Journal of Allergy and Clinical Immunology, (20100000), vol. 125, no. 2, page 1, XP026901960
OPPOSITION- RATHORE et al., "Current Perspectives on Stability of Protein Drug Products during Formulation, Fill and Finish Operations", Biotechnology Progress, (20080000), vol. 24, pages 504 - 514, XP055155930
OPPOSITION- MISBAH et al., "- Subcutaneous immunoglobulin: opportunities and outlook", Clinical and Experimental Immunology, (2009), vol. 158, no. S1, pages 51 - 59, XP002585722

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents